These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12711095)

  • 1. 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T; Meltzer HY; Ichikawa J
    Brain Res; 2003 May; 972(1-2):216-21. PubMed ID: 12711095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
    Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.
    Liégeois JF; Ichikawa J; Meltzer HY
    Brain Res; 2002 Aug; 947(2):157-65. PubMed ID: 12176156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2001 Jul; 907(1-2):151-5. PubMed ID: 11430898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex.
    Pehek EA; McFarlane HG; Maguschak K; Price B; Pluto CP
    Brain Res; 2001 Jan; 888(1):51-59. PubMed ID: 11146051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.
    Bortolozzi A; Amargós-Bosch M; Adell A; Díaz-Mataix L; Serrats J; Pons S; Artigas F
    Eur J Neurosci; 2003 Sep; 18(5):1235-46. PubMed ID: 12956722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2005 Jul; 1049(2):182-90. PubMed ID: 15936730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Kuroki T; Dai J; Meltzer HY
    Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.
    Martín-Ruiz R; Puig MV; Celada P; Shapiro DA; Roth BL; Mengod G; Artigas F
    J Neurosci; 2001 Dec; 21(24):9856-66. PubMed ID: 11739593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
    Porras G; Di Matteo V; Fracasso C; Lucas G; De Deurwaerdère P; Caccia S; Esposito E; Spampinato U
    Neuropsychopharmacology; 2002 Mar; 26(3):311-24. PubMed ID: 11850146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
    Ichikawa J; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
    J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
    Auclair A; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
    J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens.
    Leggio GM; Cathala A; Moison D; Cunningham KA; Piazza PV; Spampinato U
    Neuropharmacology; 2009 Feb; 56(2):507-13. PubMed ID: 18977370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Chung YC; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Dec; 958(1):176-84. PubMed ID: 12468043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.